METRICs Project awarded funding under TRANSCAN-3 JTC 2024

July 17, 2025

METRICs Project awarded funding under TRANSCAN-3 JTC 2024

Genetic evolution of seasonal influenza A viruses in Türkiye

July 16, 2025

Genetic evolution of seasonal influenza A viruses in Türkiye

New therapeutic target for Mesothelioma identified by İBG researchers: BUB1

July 11, 2025

New therapeutic target for Mesothelioma identified by İBG researchers: BUB1

TÜBİTAK backs growth phenotype study

July 9, 2025

TÜBİTAK backs growth phenotype study

IBG team receives ICGEB CRP grant for research on CENPA

June 25, 2025

IBG team receives ICGEB CRP grant for research on CENPA

IBG Researchers study ranked among top 10 most-cited in PROTEINS Journal

May 26, 2025

A publication led by Dr. Ezgi Karaca and Dr. Burcu Özden from the Karaca Lab at the IBG has been recognized among the Top 10 Most-Cited Papers of 2023 by the prestigious journal PROTEINS: Structure, Function, and Bioinformatics.

İBG's expertise will be transformed into products with the support of TÜSEB

May 16, 2025

A Framework Protocol aimed at strengthening the collaboration between the İzmir Biomedicine and Genome Center (İBG) and the Health Institutes of Türkiye (TÜSEB) has been signed.

A Framework Protocol signed between IBG and TÜSEB

May 15, 2025

On 15 May 2025, a Framework Protocol was signed between the Izmir Biomedicine and Genome Centre (IBG) and the Presidency of Turkish Health Institutes (TÜSEB) to strengthen cooperation in the field of health biotechnology.

The role of demography, antigenic characteristics, and phylogenetic relationships in the epidemiology of influenza B viruses

May 9, 2025

The role of demography, antigenic characteristics, and phylogenetic relationships in the epidemiology of influenza B viruses

Mobile application developed for children with Angelman syndrome

April 29, 2025

Prof. Dr. Ayşe Semra Hız Kurul, Pediatric Neurology Specialist and member of the IBG Centre Rare Diseases Platform, stated that 350 million people in the world live with an undiagnosed disease and drew attention to the importance of early diagnosis.

DEU National Cancer Week Symposium held in IBG

April 10, 2025

DEU National Cancer Week Symposium held in IBG.

Multiomics Technologies Symposium and practical workshop held

March 25, 2025

Unifying Multiomics: Bridging the Gaps Symposium and Workshop, organized by İzmir Biomedicine and Genome Center (IBG), was held on March 24, 2025. The event covered advancements in genetic research.

IBG and Sidra Medicine Sign MoU

March 19, 2025

IBG and Sidra Medicine Sign MoU

TÜBİTAK support for IBG Researchers' project

March 6, 2025

TÜBİTAK support for IBG Researchers' project

Innovative discoveries by IBG researchers granted a U.S. patent

March 6, 2025

Innovative discoveries by IBG researchers granted a U.S. patent

Students seek solutions for rare diseases on Rare Disease Day

March 5, 2025

Students seek solutions for rare diseases on Rare Disease Day.

Turkish scientists returning home through reverse brain drain receive U.S. patent for their devices

March 5, 2025

Turkish scientists working at IBG have received a patent from the U.S. Patent and Trademark Office for technologies they developed for imaging cell and retinal diseases.

İzmir Biomedicine and Genome Center’s AF-Ensemble Project receives TÜBİTAK support

March 4, 2025

The AF-Ensemble project, conducted within the İzmir Biomedicine and Genome Center (İBG), has been selected for funding under the TÜBİTAK 2509 Program.

Twelve rare and undiagnosed diseases identified through a project conducted in İzmir

Feb. 27, 2025

IBG, a project aimed at diagnosing and treating rare and undiagnosed diseases has successfully identified 12 patients over 15 months.The center was established to develop innovative technologies and products for disease prevention, diagnosis and treatment

Academic collaboration between Istanbul University-Cerrahpaşa, Dokuz Eylül University and IBG

Feb. 25, 2025

Academic collaboration between Istanbul University-Cerrahpaşa, Dokuz Eylül University and IBG

Call for competition on Rare Diseases Day

Feb. 25, 2025

The RareBoost Project, implemented by IBG and supported by the European Union Horizon 2020 ‘ERA Chairs’ program, invites young scientists to the Rare Hackathon on 28 February Rare Diseases Day.

DEU-IBG-Oxford collaboration in cardiovascular diseases

Feb. 21, 2025

Dokuz Eylül University, Izmir Biomedicine and Genome Center and Oxford University will collaborate in the health field.

Collaboration in the field of health between scientific research institutions in İzmir and Oxford

Feb. 21, 2025

Dokuz Eylül University, İzmir Biomedicine and Genome Center, and the University of Oxford have signed a protocol for scientific research and academic collaboration on cardiovascular diseases.

The active ingredient of smart cancer drugs produced abroad was developed domestically

Feb. 19, 2025

Important step for domestic cancer drug.

Incubator-integrated Electrochemical Analysis Platform published in npj Biosensing

Feb. 12, 2025

Incubator-integrated Electrochemical Analysis Platform published in npj Biosensing.

Latest insights at the Epigenetics in Rare Diseases Symposium

Feb. 7, 2025

The 'Epigenetics in Rare Diseases Symposium' was held at the Izmir Biomedicine and Genome Center (IBG) on 3 February 2025 with an intense participation.

IBG and Sidra Medicine decide on institutional collaboration in scientific research

Jan. 27, 2025

The Izmir Biomedicine and Genome Center (IBG) and Qatar-based Sidra Medicine and Research Center have decided to establish a bilateral collaboration to strengthen institutional cooperation in scientific research.

Turkish-Italian collaboration receives TÜBİTAK approval for rare disease research

Jan. 13, 2025

Turkish-Italian collaboration receives TÜBİTAK approval for rare disease research

TÜSEB Board of Management visited IBG

Jan. 7, 2025

TÜSEB Board of Directors visited Izmir Biomedicine and Genome Center (IBG) to evaluate scientific cooperation and innovative projects.

Robot developed to accelerate cell studies

Dec. 27, 2024

IBG research group leader Dr Arif Engin Çetin and his team developed a robot to combine sample preparation and cell development imaging processes, which are carried out separately in cancer and drug research in laboratories, on a single platform.

IBG researcher supported with 1.6 million Euros with ERC Consolidator Grant

Dec. 4, 2024

IBG researcher supported with 1.6 million Euros with ERC Consolidator Grant

Device developed to eliminate degenerative tissues before they turn into cancer

Dec. 4, 2024

Assoc. Prof. Serhat Tozburun and his team at IBG developed a device to eliminate abnormal tissues carrying cancer risk in the digestive system in the Clarisurge project with a grant of €1.6 million from the ERC Consolidator Grant supported by TÜBİTAK.

2024 IBG Science Day: An Inspiring Meeting

Nov. 29, 2024

2024 IBG Science Day: An Inspiring Meeting

2024 IBG Science Day: Inspirational meeting

Nov. 26, 2024

2024 IBG Science Day, held on 25 November 2024 at the IBG, brought together scientists, students and researchers from all over Türkiye with the scientific support of the Neuroscience Society of Turkey (TÜBAS).

BİDEB funding for Izmir Biomedicine and Genome Center researchers

Nov. 13, 2024

The results of the 2247-A National Leading Researchers Programme and 2247-D National Young Leaders Programme 2023, carried out by the TUBITAK Directorate of Scientist Support Programmes (BİDEB), have been announced.

Izmir Biomedicine and Genome Center participated in BIOEXPO 2024

Oct. 30, 2024

Izmir Biomedicine and Genome Center participated in BIOEXPO 2024

Applications for the IBG Science Medal are now open: Award for researchers who inspire science

Oct. 7, 2024

Izmir Biomedicine and Genome Center (IBG) has opened applications for the prestigious IBG Science Medal. The award aims to honour scientists who contribute to society through innovative research in the life sciences.

Applications for the IBG Science Medal are now open!

Oct. 4, 2024

Applications for the IBG Science Medal are now open!

Targeted microorganism detection with molecularly imprinted polymer biosensor

Oct. 3, 2024

The molecularly imprinted polymer (MIP) electrochemical biosensor developed for the rapid and selective detection of Enterococcus faecium has been published in the Journal of Electroanalytical Chemistry (IF: 4.1).

Climate change and environmental pollutants discussed at EXPOSOME-TR Symposium

Sept. 27, 2024

EXPOSOME-TR Symposium, where the effects of climate change and environmental pollutants on human health were discussed in Izmir, was held in cooperation with Izmir Biomedicine and Genome Center (IBG) and Dokuz Eylül University (DEU).

DMD Symposium held at Izmir Biomedicine and Genome Center

Sept. 23, 2024

The Duchenne Muscular Dystrophy (DMD) Symposium was held at IBG as part of the Rare Neuromuscular Disease Awareness Month. This event, organized in collaboration with IBG-RareBoost and Hedef DMD projects, aims to raise awareness.

IBG 2nd Experimental Animal Use Certificate Course was successfully completed

Sept. 20, 2024

IBG 2nd Experimental Animal Use Certificate Course was successfully completed

EXPOSOME-TR Symposium to address climate change and environmental pollutants in Turkey

Sept. 16, 2024

EXPOSOME-TR Symposium to address climate change and environmental pollutants in Turkey.

Domestic biotech cancer drugs are on the way

Sept. 3, 2024

Significant progress was achieved to overcome foreign dependency in pharmaceuticals. Turkish scientists have started to develop domestic drugs. Important studies are being carried out at IBG, to develop biotechnological drugs for cancer.

New IBG project: Innovative drug delivery system for treating bile duct cancer

Aug. 21, 2024

IBG is undertaking a new project to develop a biotechnological drug carrier system for biliary tract cancer patients. The project has been accepted within the TÜBİTAK-2515 COST Support Program.

New project from IBG: An innovative drug delivery system will be developed for biliary tract cancer treatment

Aug. 15, 2024

Izmir Biomedicine and Genome Centre (IBG) is undertaking a new project to develop a biotechnological drug carrier system for biliary tract cancer patients.

Counsellor for Science and Technology of Pakistan visited İBG

Aug. 7, 2024

Dr. Badar-ud-din Ahmed, Science and Technology Counsellor of Pakistan Embassy in Ankara, visited the Izmir Biomedicine and Genome Center (IBG).

Prof. Dr. Bayram YILMAZ was appointed as Rector of Dokuz Eylül University

July 26, 2024

Prof. Dr. Bayram YILMAZ was appointed as Rector of Dokuz Eylül University

TRANSLACORE Biobanking Training School was held at Izmir Biomedicine and Genome Center

July 23, 2024

TRANSLACORE Biobanking Training School was held at Izmir Biomedicine and Genome Center

Turkish researchers have access to supercomputers to find solutions to genetic diseases

July 1, 2024

The team of researchers from Izmir Biomedicine and Genome Center, which has gained access to the 'MareNostrum5' supercomputer developed as part of The European High Performance Computing Joint Undertaking, will find solutions to genetic diseases.

TÜBİTAK 1004 EKSPOZOM Platform came together focusing on the health impacts of climate change and environmental pollution

June 25, 2024

TUBITAK 1004 EKSPOZOM Platform project coordinators and researchers, of which Izmir Biomedicine and Genome Center (IBG) is the manager and applicant, came together at IBG to discuss potential studies in the context of project evaluation and collaboration.

IBG hosts seminar on rare diseases and biobanking training

June 15, 2024

Helene and Mikk Cederroth, who work on rare and undiagnosed diseases in Sweden, gave a seminar at IBG. A training on Biobanking was also organized at IBG on 10-12 June.

Prof. Dr. Bayram YILMAZ, Director of IBG, has been elected to the IUPS Academy

June 12, 2024

Prof. Dr. Bayram YILMAZ, Director of Izmir Biomedicine and Genome Center (IBG), has been elected a Fellow of the International Union of Physiological Sciences (IUPS) Academy of Physiology.

IBG BECAME ONE OF THE PARTNERS OF THE NANOBIO4CAN PROJECT

May 31, 2024

The kick-off meeting of the Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer (NANOBIO4CAN) Project, of which we are a partner, was held with the presentation of TÜBİTAK President Prof. Dr. Hasan Mandal.

A major development in the treatment of ovarian cancer

May 22, 2024

The research team at Izmir Biomedicine and Genome Center has developed a new drug model that does not harm healthy cells in the treatment of ovarian cancer. The model has received a patent.

İzmir Biomedicine and Genome Center Researcher's Cancer Treatment Method Receives Patent

May 8, 2024

İzmir Biomedicine and Genome Center Researcher's Cancer Treatment Method Receives Patent

PROMISING BREAKTHROUGH IN MENINGOCOCCAL VACCINE DEVELOPMENT BY IBG RESEARCHERS

April 30, 2024

A new generation vaccine with broader protective capacity at a low cost could be produced, providing affordable protection in global health.

A big step forward for the domestic and national meningitis vaccine

April 28, 2024

Under the leadership of the Izmir Biomedicine and Genome Center (IBG), researchers from Bilkent and Hacettepe Universities have developed a new generation method for a highly protective and affordable meningitis vaccine.

350 million people worldwide are living with an undiagnosed disease.

April 26, 2024

29 April World Undiagnosed Disease Day, aims to raise public awareness by drawing attention to undiagnosed diseases and to improve diagnosis by encouraging national or international cooperation.

IBG researcher received funding under TUBITAK-NSF Joint Research Program

April 17, 2024

The international project of an IBG scientist and her team received funding from the TUBITAK-ARDEB-2501 Program.

IBG’S SUCCESS AT TUBITAK 1001 PROGRAMME

Jan. 16, 2024

TUBITAK-ARDEB 2023 2nd term 1001 funding programme scientific evaluation results are announced.

IBG RESEARCHER RECEIVED THE HORIZON EUROPE JOINT PROGRAM OF NEURODEGENERATIVE DISEASE FUND

Jan. 12, 2024

IBG Researcher Receıved The Horızon Europe Joınt Program Of Neurodegeneratıve Dısease Fund.

IBG RESEARCHER RECEIVES INCENTIVE AWARD FROM TUBITAK

Jan. 2, 2024

Doç. Dr. Serap Erkek Özhan, group leader of IBG’s Disease Epigenetics Lab, is one of the researchers to receive the TUBITAK Incentive Award this year.

IBG Handover Ceremony

Dec. 21, 2023

Prof. Dr. Bayram YILMAZ took over the position from Prof. Dr. İhsan GÜRSEL with the handover ceremony held and became a new Director of IBG Center.

A new look at the molecular machinery of cell division

Oct. 24, 2023

A recent paper authored by three IBG scientists as part of a European consortium provides a reconciliary view on the early steps of kinetochore assembly during cell division

Portable Optofluidic Platform for Binding Dynamics Applications in Field Settings

Oct. 23, 2023

Dr. Arif Çetin and his colleagues have published a study on a portable optofluidic platform in the Sensors and Actuators A: Physical journal (IF: 4.6), which serves as a versatile tool for examining binding dynamics in field settings.

FOR WOMEN IN SCIENCE

Oct. 6, 2023

Dr. Sibel Kalyoncu Uzunlar from Izmir Biomedicine and Genome Center is one of the four women scientists who were awarded for the 21st year of "For Women In Science" program in Turkey, in partnership with UNESCO and L'ORÉAL.

c-Met signaling orchestrates the organ preference of metastasizing HCC cells

Sept. 12, 2023

A recent paper from Atabey Research Group may help to understand the mechanism behind intrahepatic metastasis of HCC by using lab-on-a-chip-device

GRANT SUPPORT FROM THE HORIZON EUROPE MARIE CURIE ACTIONS STAFF EXCHANGES PROGRAM

Aug. 10, 2023

İBG is happy to announce that it has been awarded grant support from the Horizon Europe Marie Curie Actions Staff Exchanges program of the European Commission.

ELSEVIER SPECIAL POSTER AWARD FOR IBG STUDENT

Aug. 7, 2023

From İzmir Biomedicine and Genome Center (IBG) Çetin Lab, Sevim Deniz Yaşar was honored with the Elsevier Special Poster Award at the 33rd International Pharmaceutical and Biomedical Analysis Symposium.

THE PREVENTION AND TREATMENT NATIONAL PLATFORM (KORTUP) MEETING

July 21, 2023

The kick-off meeting of "The Prevention and Treatment National Platform (KORTUP)" was held today at IBG!

We congratulate Prof. Dr. Ahmet YOZGATLIGİL

June 22, 2023

İBG Board Member Prof. Dr. Ahmet YOZGATLIGİL was appointed as Deputy Minister of Industry and Technology.

We congratulate our Chairman of the Board of Directors Dr. Şuayip BİRİNCİ

June 22, 2023

Dr. Şuayip BİRİNCİ, Chairman of the Board of Directors of Izmir Biomedicine and Genome Center, was reappointed as Deputy Minister of Health.

NEW COLLABORATIVE STUDY BY IBG RESEARCHER

May 11, 2023

A collaborative research group including Dr. Arif Engin ÇETİN from IBG published its latest article in the journal of Advanced Intelligent Systems.

OUR COVID-19 VACCINE DEVELOPMENT STUDIES HAVE BEEN PUBLISHED WITHIN IBG-FARMA

April 25, 2023

IBG-FARMA researchers have published their work on COVID-19 vaccine candidate in Scientific Reports.

BAGEP 2023 SCIENCE ACADEMY YOUNG SCIENTIST AWARD TO DR. SİBEL KALYONCU UZUNLAR

April 10, 2023

The 2023 results of the Science Academy Young Scientists Award (BAGEP) have been announced. From IBG, Dr. Sibel KALYONCU UZUNLAR is among 39 awarded scientists.

EuroHPC Support for Organoid Morphology Analysis System Development

April 4, 2023

The project based on the development of a system that performs morphology analyzes of organoids, prepared jointly by IBG's Therapeutic Bioengineering research group and Bioinformatics Platform (BIP), has been awarded GPU support by EuroHPC.

IBG RESEARCHER ELECTED TUBA HONORARY MEMBER

Feb. 27, 2023

Prof. Dr. Stefan Dimitrov, group leader of IBG’s Chromatin Biology and Epigenetics Laboratory is elected as TUBA Honorary Member.

A NEW STUDY UNRAVELS THE EFFECTS OF DIET-INDUCED OBESITY ON BRAIN

Feb. 7, 2023

Prof. Güneş ÖZHAN and her graduate students have recently published their work on characterization of the adverse effects of high-fat diet feeding on brain tissue in a zebrafish model, in the journal Molecular Neurobiology.

NEW MOLECULES EFFECTIVE ON OVARIAN CANCER CELLS

Jan. 24, 2023

Researchers from IBG and Dokuz Eylul University worked together to synthesize new ruthenium complexes and demonstrate their effects on ovarian cancer cells. The study was published in the journal Frontiers in Pharmacology.

A NEW STUDY ON COVID-19 FROM IBG RESEARCHERS

Jan. 24, 2023

Researchers from the Computational Systems Biology Laboratory of IBG published their latest findings on transcriptomic profiling of the samples from COVID-19 patients in the journal Viruses.

TEAR GLAND ORGANOIDS FROM INDUCED PLURIPOTENT STEM CELLS

Jan. 24, 2023

IBG’s Therapeutic Bioengineering Lab researchers and their collaborators published their findings on generation of lacrimal gland organoids from human induced pluripotent stem cells in the journal Frontiers in Cell and Developmental Biology.

NEW STUDY ON OVARIAN CANCER CELL EXOSOMES FROM IBG RESEARCHERS

Jan. 16, 2023

A new study, in which Prof. Dr. Hülya AYAR KAYALI and her research group examined the effect of exosomes released from ovarian cancer cells on target cells, was published in the journal Biomedicine & Pharmacotherapy.

DR. ARİF ENGİN ÇETİN’S RECENTLY DEVELOPED TECHNOLOGY WAS WELL RECEIVED BY THE PRESS

Dec. 30, 2022

Turkish scientists developed a new technology for the diagnosis of Familial Mediterranean Fever (FMF) in a project led by Dr. Arif Engin ÇETİN, the group leader IBG Nanophotonics and Bioidentification Systems Laboratory

IBG’s Success at TUBITAK – 1001 Funding Programme

Dec. 30, 2022

TUBITAK-ARDEB 2022 2nd term 1001 funding programme scientific evaluation results are announced.

IBG RESEARCHERS TALKED ABOUT THEIR PROJECT G-FED IN DETTO YORUM MAGAZINE

Dec. 28, 2022

Assoc. Prof. Gökhan KARAKÜLAH and Asst. Prof. Yavuz OKTAY introduced their project named G-FED, developed within their start-up company Solaris Genomic Health with the support of TÜBİTAK-TEYDEB 1507 programme.

TECHNOLOGY DEVELOPMENT FOUNDATION OF TURKEY AWARD GOES TO AN IBG RESEARCHER

Dec. 19, 2022

Dr. Arif Engin ÇETİN, group leader of Nanophotonics and Biodetection Systems Laboratory at IBG, received the “Refik Üreyen Leadership Stories in R&D Organizations Award” within the scope of the 2022 TTGV awards.

IBG RESEARCHER RECEIVED THE HORIZON EUROPE HEALTH CLUSTER RESEARCH FUND

Dec. 15, 2022

IBG researcher Dr. Gülçin ÇAKAN AKDOĞAN received grant support for her project that is a part of an international consortium on the identification of nonalcoholic steatohepatitis (NASH) biomarkers.

INTERVIEW WITH IBG STUDENT PUBLISHED IN THE BIDEB BULLETIN

Dec. 13, 2022

The interview of BIDEB (Directorate of Science Fellowships and Grant Programmes) with Didem ÖKMEN, who was a scholar in the Covid-19 STAR programme at IBG, was published in the TUBITAK BIDEB bulletin.

IBG RESEARCHER RECEIVED TOYP-TURKEY AWARD

Dec. 6, 2022

Dr. Arif Engin ÇETİN, group leader of IBG’s Nanophotonics and Biodetection Systems Laboratory, is selected as the winner of the "Science and Technical Development" category award of 2022 TOYP Turkey - Turkey's 10 Successful Young People Program.

IBG RESEARCHER RECEIVED SEDAT SİMAVİ AWARD

Dec. 2, 2022

Dr. Arif Engin ÇETİN, group leader of IBG’s Nanophotonics and Biodetection Systems Laboratory, was awarded “Health Sciences Award” within the scope of the Sedat Simavi Awards 2022.

FRUITFUL CROSS DISCIPLINARY COLLABORATION OF IBG RESEARCHERS ON MITOTIC KINASE ACTIVATION

Nov. 21, 2022

Dr. Kasım DIRIL and Dr. Ezgi KARACA collaborated to investigate the activation mechanism of mammalian Mastl kinase using in silico and in vivo methods. They published their findings in the Journal of Biomolecular Structure and Dynamics.

NEW STUDY PUBLISHED BY IBG RESEARCHERS ON MANTLE CELL LYMPHOMA

Nov. 18, 2022

Lymphoid Cancer Genomics research group and project partners published their findings in the Cells journal (IF: 7.7) on the identification of prognostically-significant genes and tumor-infiltrating immunocytes in mantle cell lymphoma.

IBG RESEARCHER RECEIVED TUBA-GEBIP AWARD

Nov. 18, 2022

Dr. Arif Engin ÇETİN, group leader of IBG’s Nanophotonics and Biodetection Systems Laboratory, was awarded the 2022 Turkish Academy Of Sciences- Outstanding Young Scientists Awards (TÜBA-GEBİP).

NOVEMBER 10th IBG SCIENCE HELD IN HYBRID FORMAT DREW ATTENTION OF PRESS AS WELL

Nov. 15, 2022

The "November 10th IBG Science Day", which we traditionally celebrate to commemorate the founder of the Republic, Gazi Mustafa Kemal Atatürk, hosted science lovers at IBG Center and online as the event is also held in a hybrid format.

2022 IBG SCIENCE MEDAL IS AWARDED

Nov. 14, 2022

This year, Assoc. Prof. Tunca DOĞAN, from Hacettepe University, Department of Computer Engineering has received the IBG Science Medal Award.

BEST POSTER AWARD IN AN INTERNATIONAL CONGRESS

Nov. 1, 2022

IBG student received the best poster award with their poster presentation entitled “Metabolomics Analysis of iPSCs Derived Organoids” at 15th International Health Informatics and Bioinformatics Symposium (HIBIT 2022).

A NEW STUDY ON TARGETING CIRCULATING TUMOR CELLS

Oct. 28, 2022

Researchers from Cakan Zebrafish Models Laboratory published their latest results on circulating tumor cell targeting capacity of albumin-based drug carrier nanoparticles in the Journal of Drug Delivery Science and Technology.

7th TURKISH-US CYTOMETRY WORKSHOP TOOK PLACE AT IBG

Oct. 5, 2022

IBG hosted the seventh flow cytometry training workshop in its premisesbetween 27th and30th of September.

A PRODUCTIVE COLLABORATION ON GRAPHENE OXIDE NANOCOMPOSITES IN ENVIRONMENTAL TOXICOLOGY

Sept. 30, 2022

Dr. Güneş ÖZHAN and her collaborators have recently published their study on graphene oxide-based nanocomposites and their toxicity determination in zebrafish in the Journal of Environmental Chemical Engineering.

BEST POSTER COMPETITION AWARD FOR IBG STUDENT

Sept. 21, 2022

Hezzal KÜÇÜKSELBES from Cetin Lab at IBG was awarded the third prize in the “Best Poster Competition” at FOTONİK 2022.

ASSOC. PROF SERHAT TOZBURUN’S RECENTLY DEVELOPPED AND PATENTED TECHNOLOGY WAS WELL RECEIVED BY THE PRESS

Sept. 2, 2022

Assoc. Prof. Serhat Tozburun and his team succeeded at developing diagnostic methods such as ultrasound and laser scanning imaging by developing a technology that can simultaneously display blood flow rates in different vessels.

DEU & PRESIDENTIAL HR OFFICE VISITED IBG

Aug. 31, 2022

DEU Rector Prof. Dr. Nükhet Hotar and Assoc. Prof. Salim Atay, President of Republic of Türkiye Human Resources Office and their accompanying delegations visited the Center and received information about the activities at IBG.

NEW METHOD DEVELOPED BY IBG RESEARCHER RECEIVED PATENT REGISTRATION

Aug. 19, 2022

The Turkish Patent and Trademark Office decided to patent a new surface-scanning method that produces wide and dynamic time spacing between images in microscopic imaging, invented by Assoc. Prof. Serhat TOZBURUN at IBG.

IBG RESEARCHER IN A COLLABORATIVE EU TRANSCAN-3 ERA-NET PROJECT

Aug. 17, 2022

Assoc. Prof. Can KÜÇÜK is involved as a researcher in a multinational TRANSCAN-3 ERA-NET project, which aims to improve immunotherapy against aggressive colorectal cancers with metastasis.

BIOPHOTONIC AND OPTICAL IMAGING LABORATORY RECEIVES TUSEB SUPPORT

Aug. 12, 2022

Within the scope of the supported project, the researchers aim to develop an optically clear endoscope cap design that can provide local irreversible electroporation-induced non-thermal ablation of target mucosal tissue.

IBG RESEARCHER RECEIVED HEALTH TECHNOLOGIES R&D GRANT FROM TUSEB

Aug. 9, 2022

Researchers of Çakan Zebrafish Models Laboratory aim to develop a patient specific drug response test for personalized treatment of Ovarian Cancer within the scope of the support.

IBG RESEARCHERS RECEIVED THE TURKISH SOCIETY OF HEMATOLOGY GRANT SUPPORT

July 28, 2022

Researchers from Özhan Lab will be supported by the Turkish Society of Hematology for their project on developping an in vivo screening platform for personalized treatment of leukemia.

NEW PUBLICATION FROM IBG RESEARCHERS ON AUTISM

July 28, 2022

Researchers from IBG and their collaborators published their findings on the investigation of “de novo structural variants (SVs)” in dizygotic twins with autism in the Journal of Autism and Developmental Disorders.

DEU - THEQC & DEPARK VISITED IBG

July 27, 2022

DEU VR Prof. Dr. Fatma Duygu ÖZEL DEMİRALP; THEQ President Prof. Dr. Mr. Muhsin KAR, DEU Sec. Gen. Engin BASMACI, DEPARK GM Prof. Dr. Özgür ÖZÇELİK and their valuable team members visited the Center and briefed on the ongoing R&D activities at IBG.

BLOOD AS LIQUID BIOPSY FOR IMPROVED DIAGNOSIS AND PROGNOSIS OF FOLLICULAR LYMPHOMA

July 8, 2022

Researchers from the Lymphoid Cancer Genomics Lab at IBG and their collaborators published their findings on the investigation of somatic mutations in circulating cell-free DNA (cfDNA) of follicular lymphoma (FL) patients in Frontiers in Oncology.

ASSOC. PROF. DUYGU SAĞ IS ELECTED AS A COMMITTEE MEMBER OF THE TURKISH NATIONAL COMMISSION FOR UNESCO

July 5, 2022

A research group leader at IBG,Assoc. Prof. Duygu SAĞ, is elected as a member of the “Natural Sciences Committee of the Turkish National Commission for UNESCO”.

UNESCO, Turkish National Commission

The Success of IBG Researchers at the 8th International Congress of the Molecular Biology Association of Turkey

June 21, 2022

Researchers from Ozhan Lab., Guven Lab. and Senturk Lab. have been awarded two poster prizes and three PIs from IBG were among the main speakers at the 8th International Congress of the Molecular Biology Association of Turkey.

ZEBRAFISH AS A PLATFORM TO MODEL HUMAN DISEASES BASED ON CRISPR GENOME EDITING TECHNOLOGY

June 1, 2022

Dr. Güneş ÖZHAN, Dr. Evin İŞCAN, Uğur BORA and Umut ÇAĞIRAL have been awarded first prize in the UN IOM Aegean Start-Ups Technology Based Entrepreneurship Program.

A DISPOSABLE THERAPEUTIC APPARATUS COMPATIBLE WITH FLEXIBLE ENDOSCOPES AND A THERAPY GUIDANCE SOFTWARE SYSTEM

June 1, 2022

Assoc. Prof. Dr. Serhat TOZBURUN, Merve TÜRKER BURHAN, Hanife GÖKKAN and Emirhan TOSUN have been awarded the second prize in the UN IOM Aegean Start-Ups Technology Based Entrepreneurship Program.

INVESTIGATION OF BIOPHARMACEUTICAL EFFICACIES THROUGH ANTIBODY ENGINEERING APPROACHES

May 18, 2022

IBG researchers published their findings in Scientific Reports about anti-angiogenesis antibody fragments used in the treatment of cancer and other diseases.

A FRUITFUL COLLABORATION ON CHARACTERIZATION OF A NOVEL MYH7 VARIANT USING CRISPR/CAS9 GENOME EDITING TECHNOLOGY IN ZEBRAFISH

May 16, 2022

Dr. Güneş ÖZHAN, her PhD student Uğur BORA and their collaborators from the Royan Institute have recently published a work on MYH7 gene.

A NOVEL PROTOCOL TO IMPROVE SKELETAL MUSCLE TISSUE ENGINEERING

April 15, 2022

A collaborative research group, involving Dr Athanasia Pavlopoulou from IBG, published its latest study in the journal Cellular and Molecular Life Sciences (CMLS)

A NEW INTERNATIONAL AWARD FROM THE AMERICAN SOCIETY OF HEMATOLOGY TO ASSOC. PROF. CAN KÜÇÜK

April 15, 2022

Another award to Assoc. Prof. Can KÜÇÜK from Turkey granted by American Society of Hematology in its 64 years of history!

Results of BİDEB 2247-A National Leader Researchers Program 2021 applications have been announced.

April 8, 2022

IBG's Success in BİDEP 2247-A Program

PLASMONIC CELL-MASS ACCUMULATION PROFILING PLATFORM FOR DETERMINING THERAPEUTIC RESPONSES OF CANCER CELLS

April 7, 2022

A patent on a new technique and device developed by Nanophotonics and Biodetection Systems Laboratory group leader Arif Engin ÇETİN and his team at IBG was granted in Turkey.

IBG RESEARCHER RECEIVED DR AYSUN-AHMET KÜÇÜKEL MEDICINE AWARD

March 18, 2022

Organized by Güven Healthcare Group since 2008, Dr. Aysun-Ahmet KÜÇÜKEL Medicine Awards found their winners on March 14th Medicine Day.

INTERVIEW IN DETTO YORUM MAGAZINE

Jan. 24, 2022

IBG Neuro-genomics Lab research group leader Dr. Yavuz OKTAY and IBG-Bioinformatics Platform director Assoc. Prof. Gökhan KARAKÜLAH talked about the start-up they established in DEPARK, and its product.

IBG GROUP LEADER IS AWARDED EMBO INSTALLATION GRANT

Jan. 20, 2022

EMBO announced that six life scientists have been selected to receive installation grants. Dr Seyit KALE, group leader of the Computational Biophysics Lab at IBG, is among them.

NEW COLLABORATIVE STUDY BY IBG RESEARCHER

Jan. 13, 2022

A collaborative research group including Dr. Arif Engin ÇETİN from IBG published its latest article in the journal Nanophotonics.

A COMPREHENSIVE ANALYSIS OF NEURONAL DIFFERENTIATION

Dec. 16, 2021

Researchers from IBG identified the molecular hallmarks of different stages of neuronal differentiation and published their results in Frontiers in Cell and Developmental Biology.

INTERACTION OF NICKEL FERRITE NANOPARTICLES WITH NUCLEIC ACIDS

Dec. 15, 2021

A collaborative research group including Dr. Arif Engin ÇETİN from IBG published its latest article in the journal Colloids and Surfaces B: Biointerfaces.

STEM CELL AND ORGANOID TECHNOLOGIES LAB IN MEDIMAGAZIN

Dec. 14, 2021

The translational work and projects of Prof. Dr. Esra ERDAL and her group were featured in the latest issue of Medimagazin.

IBG RESEARCHER RECEIVES INCENTIVE AWARD FROM TUBITAK

Dec. 2, 2021

Dr Arif Engin ÇETİN, group leader of IBG’s Nanophotonics and Biodetection Systems Lab, is one of the researchers to receive the TUBITAK Incentive Award this year.

GENETIC CHARACTERISTICS OF NEUROGENETIC DISEASES IN A CONSANGUINEOUS POPULATION

Nov. 26, 2021

Prof. Dr. Semra HIZ and Dr. Yavuz OKTAY published their results on the genetic analysis of neurogenetic diseases in a Turkish consanguineous population in the prestigious journal, Brain.

USAGE OF THE DRUG DMF FOR BRAIN INFLAMMATION AND SICKNESS BEHAVIOUR

Nov. 18, 2021

Prof. Dr Şermin GENÇ and her group members discovered that Dimethyl Fumarate (DMF) can be used to alleviate the effects of neuroinflammation and sickness behavior (https://doi.org/10.3389/fimmu.2021.737065).

THE AGREEMENT SIGNED AMONG IBG/OZBIO AND NOBEL PHARMACEUTICALS RECEIVED WIDE MEDIA COVERAGE

Nov. 15, 2021

The important agreement in which four institutions came together for a medicine, that will be produced in Turkey, attracted attention in the media.

2021 IBG SCIENCE MEDAL IS AWARDED

Nov. 12, 2021

This year, Dr. Gökhan DEMİREL from Gazi University, Department of Chemistry has received the IBG Science Medal Award.

ASSOC. PROF SERHAT TOZBURUN’S APPROVED PATENT WAS WELL RECEIVED BY THE PRESS

Nov. 12, 2021

The news of the approved patent of the device, which was developed to facilitate the diagnosis of diseases in difficult areas of the eye, was published in important media channels.

HYBRID 10TH OF NOVEMBER IBG SCIENCE DAY DRAWS INTEREST

Nov. 11, 2021

Our traditional “10th of November IBG Science Day”, organised each year to commemorate the founder of the republic Gazi Mustafa Kemal Atatürk with science, was held with a hybrid format, allowing science lovers to come together at IBG and online.

ASSOCIATE PROF DUYGU SAĞ BECAME THE VOICE OF UNESCO TURKEY

Nov. 11, 2021

As part of the 75th anniversary celebrations of UNESCO, the UNESCO Turkey testimony was declared by Assoc. Prof Duygu SAĞ.

OPTIC IMAGING METHOD DEVELOPED AT IBG RECEIVES PATENT REGISTRATION

Oct. 27, 2021

A new technique and device developed at IBG by group leader of the Biophotonics and Optical Imaging Lab. Assoc. Prof. Serhat TOZBURUN and his team qualified for patenting.

SIGNING CEREMONY BETWEEN IBG-OZBIO AND NOBEL PHARMACEUTICALS

Oct. 22, 2021

An agreement was signed with Nobel Pharmaceuticals for the manufacturing of a biosimilar in Turkey, which was developed jointly by IBG and OzBio and is used in the treatment of a rare disease.

IBG VISIT OF INVESTORS

Oct. 20, 2021

Founder of Arya Women’s Investment Platform Ahu BÜYÜKKUŞOĞLU SERTER visited IBG on Thursday, 14th of October, followed by the visit of Managing Partner of IDA Capital Cem BAYTOK on Friday, 15th of October.

TEKNOFEST ACHIEVEMENT OF STUDENTS

Oct. 5, 2021

High school students scientifically supported by members of IBG’s Computational Structural Biology Lab won first prize in TEKNOFEST 2021’s Biotechnology Innovation Competition.

IBG’S FIRST TRANSGENIC MICE

Oct. 1, 2021

Gene Targeting and Transgenic Models Platform at IBG has recently created a genetically modified (transgenic) mouse model in their laboratories for the first time.

IBG STUDENT’S TEKNOFEST 2021 ACHIEVEMENT

Oct. 1, 2021

IBG Master’s student Fatma Kurul and her team came second with their Project “ctDNA Detecting Biosensor Production for the Early Detection of Cancer” in TEKNOFEST 2021’s Biotechnology and Innovation Competition, University and Above Level Idea Category.

DISCOVERY OF BIOMARKERS FOR AML

Oct. 1, 2021

A collaborative research group, involving IBG researchers, published its latest results on the identification of diagnostic and prognostic markers of Acute Myeloid Leukemia (AML) in the International Journal of Molecular Sciences.

DR. ÇETİN ALİ DÖNMEZ AND PROF. DR. GÖKHAN HOTAMIŞLIGİL VISITED IBG

Sept. 29, 2021

Dr. Çetin Ali Dönmez, Deputy Minister of Republic Of Turkey Ministry of Industry and Technology, and Prof.Dr. Gökhan Hotamışlıgil, member of IBG Advisory Board, visited IBG and obtained information on the ongoing activities of IBG on 25th of September.

JOINT MIND PLATFORM STUDY HELD AT IBG

Sept. 21, 2021

The Joint Mind Platform® Study was held under the coordination of TÜBİTAK TÜSSİDE on 17-18 September with the participation of IBG employees.

MINING FOR NATURAL COMPOUNDS WITH ANTICANCER ACTIVITY

Sept. 9, 2021

IBG researchers published their latest collaborative study, which uses a systems biology approach to mine natural products for their anticancer capability, in the journal Oxidative Medicine and Cellular Longevity.

GROUNDBREAKING NEW STUDY ON RETT SYNDROME BY IBG RESEARCHER

July 12, 2021

Dr. Stefan Dimitrov and his collaborators published their study in Science that changes the textbook information on Rett Syndrome.(DOI: 10.1126/science.abd5581)

NEW ARTICLE ON A HANDHELD BIOSENSOR FOR VIRUS DETECTION

June 23, 2021

The article on a handheld plasmonic biosensor for virus detection in field-settings, developed by Dr. Arif ÇETİN and his collaborators, was published in the journal Sensors and Actuators B: Chemical.

IBG FEATURES IN SANAYI NEWSPAPER

June 15, 2021

The newspaper specialised in the industry field, Sanayi, published an article about IBG in its 552nd issue.

IBG AND DEPARK SIGN COOPERATION PROTOCOL

June 12, 2021

Izmir Biomedicine and Genome Center (IBG) and Dokuz Eylül University Technopark (DEPARK) have reached an agreement to cooperate on technology transfer processes.

NEW GENOMICS STUDY ON AUTISM FROM IBG

June 9, 2021

A study group formed of researchers from the Neuro-Genomics Lab and IBG-BIP published their results on the analysis of alternatively spliced genes and their co-expression networks in dizygotic twins with autism in the journal Genomics.

MEHMET FATİH KACIR AND PROF. DR. HASAN MANDAL VISITED IBG

June 9, 2021

Mehmet Fatih KACIR, Deputy Minister of Republic Of Turkey Ministry of Industry and Technology, and Prof. Dr. Hasan MANDAL, President of TUBITAK, visited IBG Center and obtained information on the ongoing activities of IBG on Monday, 31st of May.

A NEW STUDY ON WNT MODIFICATION IN THE NEURAL TISSUES

June 2, 2021

Researchers from Development and Regeneration Lab at IBG and their international collaborators have recently published their work on the lipidation of the Wnt3 ligand in zebrafish neural tissues in the journal Frontiers in Cell and Developmental Biology.

A NEW STUDY FROM IBG: MEASURING SINGLE CELL GROWTH

May 27, 2021

Dr. Arif Engin Çetin and his collaborators developed a plasmonic platform that can precisely measure cell growth, and published their study in the prestigious journal ACS Nano.

NEW ARTICLE FROM IBG ON THE MECHANISM OF NEUROPROTECTION

May 26, 2021

Researchers of the Neurodegeneration and Neuroprotection Lab at IBG published their latest study on the mechanism of ethyl pyruvate’s anti-inflammatory neuroprotective effect in the journal Antioxidants.

THE STUDY OF THE GENOMICS OF LYMPHOID CANCERS GROUP IS AMONG HIGHLIGHTED ARTICLES

May 24, 2021

The publication of the study conducted by IBG’s Lymphoid Cancer Genomics research group and their international partners was selected to be highlighted by the Journal of Leukocyte Biology this month.

A NEW METHODOLOGY IN THE FIELD OF SOFT ROBOTICS FROM IBG RESEARCHER

May 21, 2021

Dr. Arif Engin Çetin published his new work, performed in collaboration with the researchers from Gazi University, in the journal Advanced Optical Materials.

DETERMINANTS OF CANCER CELL RESISTANCE TO RADIATION TREATMENT

May 7, 2021

A research group, under the leadership of Dr Athanasia Pavlopoulou, published its latest results on the molecular determinants of cancer cell resistance to ionizing radiation in the journal Frontiers in Cell and Developmental Biology.

TRT HABER NEWS CHANNEL INTERVIEWS MEMBERS OF IBG-BIOBANK ON BIOBANKS

April 5, 2021

TRT Haber News Channel Interviews Members of IBG-Biobank on Biobanks

THE STORY OF A RARE DISEASE PATIENT RECEIVES MEDIA COVERAGE

April 5, 2021

The team involving researchers Dr. Yavuz OKTAY and Prof. Dr. Semra HIZ from Izmir Biomedicine and Genome Center and Dokuz Eylul University (DEU) conducted research which has given chance at life to Yakup Altun and his two cousins who have a rare disease.

NEW SARS-CoV-2 GENOME STUDY PERFORMED BY IBG RESEARCHERS IS PUBLISHED

March 23, 2021

A group formed to investigate the mutation dynamics and evolution of the SARS-CoV-2 genome published their latest findings on the different selection dynamics of the S and RdRp genes in the Infection, Genetics and Evolution journal.

SARS-CoV-2, Genome

IBG RESEARCHERS RECEIVE 2020 PRESENS SENSORPLUG COMPETITION AWARD

March 19, 2021

PreSens, a leading company in the field of optical sensors, announced the winner of the 2020 SensorPlug Competition.

IBG FEATURES IN ANAHTAR, THE MONTHLY JOURNAL OF MINISTRY OF INDUSTRY

March 15, 2021

Anahtar, which is the monthly publication of the Ministry of Industry and Technology of Turkey, published an article about Izmir Biomedicine and Genome Center in its March 2021 issue.

A NEW STUDY ON THE TUMORIGENICITY OF DRUG INDUCED SENESCENCE

March 12, 2021

Researchers from Erdal Lab at IBG recently published their results in the journal Molecular Oncology.

HAPPY INTERNATIONAL WOMEN’S DAY

March 8, 2021

As Izmir Biomedicine and Genome Center, we wish all women a happy 8th of March International Women’s Day.

SUCCESS IN TUBITAK’S NATIONAL POST-DOCTORAL RESEARCH SCHOLARSHIP PROGRAM

Feb. 8, 2021

TUBITAK's “2218 National Post-Doctoral Research Fellowship Program 2020” evaluation process has been completed. Six of seven young researchers who applied with their project proposals to do research in IBG were awarded the scholarship.

IBG RESEARCHER RECEIVES OCEAN INSIGHT INSPIRATION AWARD

Feb. 3, 2021

Ocean Insight, a leading company in its field, announced the winners of 2020-2021 Grant Program. Among many international applications, Dr. Arif Engin Çetin’s proposal was entitled to receive the ‘Ocean Inspiration Award’.

DEU RECTOR PROF. DR. NÜKHET HOTAR VISITED IBG

Jan. 21, 2021

The Rector of Dokuz Eylul University Prof. Dr. Nükhet Hotar, along with executives of the university, visited Izmir Biomedicine and Genome Center and obtained information on the ongoing activities of IBG.

PROF. DR. HASAN MANDAL, THE PRESIDENT OF TUBITAK, VISITED IBG

Jan. 18, 2021

The President of TUBITAK Prof. Dr. Hasan Mandal visited İzmir Biomedicine and Genome Center on January 15th.

DR. ARIF ÇETIN’S “TUSEB AZIZ SANCAR ENCOURAGEMENT AWARD” WAS PUBLISHED IN THE PRESS

Jan. 8, 2021

TUSEB AZIZ SANCAR ENCOURAGEMENT AWARD

THE RESEARCH STUDY OF ASSOC. PROF. DUYGU SAG AND HER PARTNERS ON A NEW IMMUNOSTIMULANT MOLECULE WAS WELL RECEIVED BY THE PRESS

Jan. 8, 2021

The Research Study on a new immunostimulant molecule was well received by the press.

NEW STUDY ON REGENERATING ZEBRA FISH BRAIN

Jan. 4, 2021

Researchers from the Development and Regeneration Lab at IBG have recently published their work on the comparative transcriptome analysis of the regenerating zebra fish brain in the Frontiers in Cell and Developmental Biology journal.

A NEW PATENT FROM IBG RESEARCHER

Dec. 24, 2020

Results of a research study performed by Assoc. Prof. Duygu Sağ, group leader of IBG’s Cancer Immunology Lab, and researchers from IZTECH (Izmir Institute of Technology) Departments of Bioengineering and Chemistry were approved to be patented.

Patent

AN INTERNATIONAL COLLABORATIVE STUDY DEMONSTRATES THE ROLE OF EPIGENETICS IN THE STRUCTURAL DIVERSITY OF CHROMATIN

Dec. 7, 2020

A research study which involves Dr. Seyit Kale, the group leader of the Computational Biophysics lab at IBG, and researchers from the U.S. NIH and Queen's University of Canada was recently published in the prestigious journal Molecular Cell (IF: 15.6)

2020 IBG SCIENCE MEDAL IS AWARDED

Nov. 12, 2020

This year, Dr. Elif Nur Fırat Karalar from Koç University Molecular Biology and Genetics Department has received the IBG Science Medal Award.

ONLINE “NOVEMBER 10 IBG SCIENCE DAY” RECEIVED GREAT APPRECIATION BY SCIENCE LOVERS

Nov. 11, 2020

“November 10 IBG Science Day”, that has been traditionalised by IBG to commemorate the founder of the Turkish Republic Mustafa Kemal Atatürk, was broadcast online this year.

IBG RESEARCHER RECEIVES 2020 TUSEB AZIZ SANCAR AWARD

Nov. 5, 2020

Dr. Arif Engin Çetin, group leader of IBG’s Nanophotonics and Biodetection Systems Lab, is one of the three researchers to receive the “TUSEB Aziz Sancar Encouragement Award” this year.

IBG DIRECTOR PROF. MEHMET ÖZTÜRK RECEIVES THE “DISTINGUISHED GRADUATE” AWARD

Oct. 16, 2020

Since 2018, Gazi University Faculty of Pharmacy in Ankara has been awarding, each year, its outstanding graduates who are pioneers and make a difference in the fields of science and pharmacy.

A Collaborative Study on The Treatment of Non-Alcoholic Fatty Liver Disease

Oct. 12, 2020

Gastroenterology (IF 17.3) (DOI:10.1053/j.gastro.2020.05.056)

Protein-based original drug development was launched at Izmir Biomedicine and Genome Center

Sept. 8, 2020

IBG, the establishment of which began almost 20 years ago under Dokuz Eylul University (DEU) and which receives funding from many organisations such as TUBITAK, became one of Turkey’s first four thematic research centres in 2018.

Drug Analysis and Control Laboratories were launched at Izmir Biomedicine and Genome Center

Aug. 17, 2020

Turkey’s first Drug Analysis and Control Laboratories with a GLP certificate were launched in Izmir

First Animal Tests for the Coronavirus Vaccination Gave Positive Results

Aug. 17, 2020

IBG Director Prof. Dr. Ozturk stated that they have obtained positive results from the laboratory experiments and animal testing in relation to the work conducted on vaccination, prophylactic and medicinal drugs during the Covid-19 process.

THE OPENING OF GLP CERTIFIED DRUG ANALYSIS AND CONTROL LABORATORIES

Aug. 12, 2020

Turkey’s first OECD GLP certified Drug Analysis and Control Laboratories were opened with a ceremony at IBG on Monday, 10th of August in IBG’s Aziz Sancar Auditorium.

IBG MOURNS FORMER ADVISORY BOARD CHAIR HERMANN BUJARD

Aug. 7, 2020

We, IBG family, are deeply saddened by the loss of Prof. Hermann Bujard (1934-2020).

A COLLABORATIVE NEW STUDY: PLASMON-COUPLED PHOTOCAPACITOR NEUROMODULATORS

July 27, 2020

Dr. Arif Engin Çetin, who is the group leader of Nanophotonics and Biodetection Systems Lab at IBG, has published his new work.

A NEW STUDY FROM IBG: THE ROLE OF A NON-CODING RNA IN THE HYBRID EPITHELIAL/MESENCHYMAL PHENOTYPE

July 21, 2020

Researchers from Atabey Lab published their study on the regulation of the metastatic capabilities of liver cancer cells in Cell Communication and Signalling journal (https://doi.org/10.1186/s12964-020-00602-0).

Mehmet Öztürk: Whatever is done to produce the vaccine all around the world; is also being done in our center...

June 22, 2020

CUMHURIYET'S INTERVIEW WITH IBG DIRECTOR PROF. DR. MEHMET OZTURK

LATEST SARS-COV2 GENOME RESEARCH BY IBG RESEARCHERS

June 19, 2020

The manuscript with the title of; ‘Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp’, is just published in Biorxiv. (https://t.co/TY7Wve7Pdz)

IBG IN TURKEY’S BIOPHARMA REPORT

May 22, 2020

Global Business Report (GBR), in collaboration with Pharma Industry Employer’s Union (IEIS), published a comprehensive report of Turkey’s pharmaceuticals and biotechnology industry for the benefit of international and local stakeholders alike.

TRACKING THE SARS-COV2 EVOLUTION

May 22, 2020

Dr.s Yavuz Oktay and Gökhan Karakülah, research group leaders at IBG, and an IBG student Doğa Eskier have just published their in-silico analysis on the effects of SARS-Cov2 mutations on the viral properties and disease characteristics at Biorxiv.

AN IMPORTANT SARS-COV2 GENOME EVOLUTION STUDY FROM IBG RESEARCHER

May 4, 2020

Dr. Pavlopoulou, together with her collaborators from Italy and Greece, has just published their study on codon usage and evolutionary divergences of SARS-Cov2 genes in the internationally respected scientific journal, Viruses.

DR. EZGI KARACA BECAME THE FIFTH EMBO INSTALLATION GRANTEE FROM IBG

May 1, 2020

EMBO Installation Grants support early-career scientists establishing independent laboratories.

TUBITAK PRESIDENT PROF. DR. HASAN MANDAL MEETS IBG RESEARCHERS

April 30, 2020

IBG researchers who have started two Covid-19 related research projects supported by TUBITAK held a very efficient meeting with TUBITAK President Prof. Dr. Hasan Mandal via video-conferencing on Thursday, 30th April.

A COLLABORATIVE EFFORT INVOLVING THREE IBG RESEARCHERS SHEDS LIGHT ON AN IMPORTANT PHENOMENON IN CELL DIVISION

April 28, 2020

A research study aiming to reveal the mechanism of the regulation of chromosome segregation during cell division brought together several experts from France, Germany, Czech Republic and Turkey.

HAPPY WORLD DNA DAY!

April 25, 2020

Every year on 25th of April, we celebrate World DNA Day which commemorates the discovery of DNA’s double helix by Watson, Crick, Franklin and Wilkins in 1953 and the successful completion of the Human Genome Project in 2003.

“TUSEB-DOKUZ EYLUL UNIVERSITY COVID-19 DIAGNOSIS CENTER” FOUNDED IN IZMIR WITH THE SUPPORT OF IBG

April 13, 2020

Although following from behind, Coronavirus keeps on spreading rapidly in our country. In the fight against the Covid-19 outbreak, the timely and accurate detection of the SARS-Cov2 virus in humans has critical importance.

TWO IBG RESEARCHERS RECEIVED THE SCIENCE ACADEMY YOUNG SCIENTISTS AWARD (BAGEP)

April 10, 2020

The Turkish Science Academy’s 2020 Young Scientists Award (BAGEP) results were announced. Dr. Ezgi Karaca ve Dr. Serhat Tozburun from IBG were listed among 40 young researchers from a range of different fields.

A COLLABORATIVE EFFORT INVOLVING AN IBG RESEARCHER UNVEILS THE ROLE OF A HISTONE VARIANT IN TRANSCRIPTION

April 10, 2020

A research study which involves the collaboration of research centers from Lyon and Grenoble in France and IBG in Turkey was published in the highly respected scientific journal Nucleic Acid Research (10.1093/nar/gkaa157).

IBG Becomes the “Shield” of DEU Clinicians and Healthcare Providers

April 8, 2020

With the lead of Dr. Arif Engin Çetin, we are producing face shields in our lab using 3D Printing techniques in just 29 minutes. We have made 48 face shields for Dokuz Eylul University (DEU) hospital and 55 for the other organisations so far.

IBG Researcher Dr. Yavuz Oktay Takes Part in a Transcontinental Rare Disease Genomics Project Funded by the Prestigious MRC

April 7, 2020

After receiving the ERA-Chair grant award for our RareBoost project, we are very happy to announce a second international success in the field of rare diseases.

IBG Director Prof. Dr. Mehmet Öztürk to Speak at the Online Conference Organised by the Covid-19 Turkey Platform

March 31, 2020

The Covid-19 Drug and Vaccine Development Online Conference will take place on Thursday 2nd April 2020.

IZMIR BIOMEDICINE AND GENOME CENTER (IBG) RECEIVES THE INTERNATIONAL ‘ERA-CHAIR’ GRANT ON RARE DISEASES RESEARCH

March 28, 2020

The European Commission announced the recipients of the latest Horizon2020 ERA-CHAIR grant call.

RESEARCHERS FROM IZMIR BIOMEDICINE AND GENOME CENTER (IBG) DISCUSSED POTENTIAL WAYS TO CONTRIBUTE TO TACKLING THE SARS-CoV2 OUTBREAK

March 25, 2020

We recently witnessed how quickly a new infection can change people’s lives. It also reminded us of the importance of keeping scientifically informed, acting promptly, and more importantly, using a scientific approach to combat threats.

A Collaboration Protocol was Signed Between Izmir Biomedicine and Genome Center and Ege University

March 16, 2020

Izmir Biomedicine and Genome Center (IBG) and Ege University Have Agreed to Collaborate on the Areas of Education, Research and Technology Development

Turkish scientists have developed a portable microscope with high-resolution imaging

Feb. 24, 2020

Using the imaging features of mobile phones, a battery-operated microscope which can enlarge images more than commercial microscopes was developed at Izmir Biomedicine and Genome Center.

Turkish scientists have developed a portable device that is able to detect the H1N1 virus in 5 minutes

Jan. 29, 2020

A local and national portable device was manufactured to be able to detect the H1N1 virus. The work conducted to develop the device lasted a total of 1.5 years, including the process to set up the chemical and biological protocols required by the system.

Research Infrastructure Monitoring and Competence Evaluation Committee visited IBG (Izmir Biomedicine and Genome Center)

Jan. 16, 2020

Research Infrastructure Monitoring and Competence Evaluation Committee visited IBG (Izmir Biomedicine and Genome Center)

Assoc. Prof. Duygu Sağ receives METU Parlar Foundation Research Incentive Award

Dec. 31, 2019

The Honour, Science, and Research Incentive Awards, given by the METU Prof. Mustafa N. Parlar Education and Research Foundation, were awarded on December 19th 2019 at the METU Culture and Convention Centre.

Significant step from Izmir Biomedicine and Genome Center towards the production of local pharmaceuticals

Dec. 30, 2019

Izmir Biomedicine and Genome Center has succeeded in becoming Turkey’s first drug analysis laboratory entitled to obtain the GLP certificate required to run preclinical tests on molecules developed by Turkish companies for locally produced drugs.

IBG Promotion and Cooperation Meeting

Dec. 17, 2019

Within the framework of Public-University-Industry Cooperation (KUSI) activities carried out by the Turkish Ministry of Industry and Technology, it is aimed to strengthen research infrastructures and industrial cooperation.

Cooperation Agreement with VSY Biotechnology

Dec. 17, 2019

With the objective of further improving its “know-how” on eye diseases, VSY Biotechnology has chosen to collaborate with IBG (Izmir Biomedicine and Genome Center) to develop novel pharmaceuticals.

Awards for IBG Researchers at the Trailblazers in Oncology Summit

Nov. 22, 2019

The Turkish Association for Cancer Research and Control (TACRC) hosted the Trailblazers in Oncology Summit in Antalya between 14-16 November 2019.

Meaningful Cooperation in the Pharmaceutical Industry

Nov. 20, 2019

Izmir Biomedicine and Genome Center (IBG), Turkey’s first thematic research center in the healthcare field, and pharmaceutical company Merck have signed a joint declaration of labour.

Advisory Board Meeting

Nov. 19, 2019

Izmir Biomedicine and Genome Center, which has an international multidisciplinary structure, held its second Advisory Board meeting this year on 8-9 November 2019.

The first preclinical laboratory in Turkey working in compliance with GLP Regulations has successfully completed the OECD GLP audit

Nov. 18, 2019

TURKAK, the Monitoring Authority of TURKEY in the field of Good Laboratory Practices (GLP) has participated in an ‘evaluation audit’ by the Organization for Economic Cooperation and Development (OECD) between 04.11.2019 and 08.11.2019.

GLP, OECD, TÜRKAK

IBG Science Medal Awarded for the First Time

Nov. 18, 2019

IBG Science Medal Award was given to Assoc. Prof. Dr. Tamer ÖNDER

Mustafa Kemal Atatürk, founder of the Republic of Turkey, was commemorated with IBG Science Day on November 10th

Nov. 15, 2019

Izmir Biomedicine and Genome Center (IBG), Turkey’s first thematic research center in the healthcare field, hosted ‘10th of November IBG Science Day’ to commemorate Mustafa Kemal Atatürk with science on the 81st anniversary of his death.

Orhan Bursalı: Women scientists are rapidly becoming prominent...

Nov. 14, 2019

İzmir’deki bilim şenliğinde salonu dolduran kalabalığa bakıyorum, genç kadınlar çoğunlukta gözüküyor. Bu yeni bir gözlemim değil. İzmir Biyotıp ve Genom Merkezi’nde (İBG) bulunan araştırma gruplarına liderlik yapanların yarısı kadın.

Kadın Biliminsanları, İBG-Merck Anlaşması

Scientifically honorable moments and IBG

Nov. 14, 2019

İzmir Biyotıp ve Genom Merkezi (IBG) 10 Kasım’ı, çok anlamlı ve bilim madalyası da verdiği bilimsel bir şölenle kutladı.

November 10 IBG Science Day

Minister of Industry and Technology Mustafa Varank visited IBG

Nov. 10, 2019

Minister of Industry and Technology Mustafa Varank, Izmir Deputy Hamza Dağ, President of TUBITAK Prof. Dr. Hasan Mandal, Izmir Governor Erol Ayyıldız and the Governor of Balçova Süleyman Özçakıcı visited IBG on Wednesday, 09 October 2019.

Prof. Mehmet Ozturk attended the CRCL International Cancer Symposium in Lyon as a guest of honour and spoke about foundership work in France and Turkey

Oct. 7, 2019

Izmir Biomedicine and Genome Center IBG’s Founding Director Prof. Mehmet Ozturk attended the 4th International Cancer Symposium organised by the Cancer Research Center of Lyon CRCL (http://www.crcl.fr) between 1-4 October 2019 as a guest of honour.

TÜSEB (Health Institutes of Turkey) President Prof. Dr. Adil Mardinoğlu and General Secretary Prof. Dr. Hasan Türkez visited Izmir Biomedicine and Genome Center (IBG)

Aug. 23, 2019

TÜSEB (Health Institutes of Turkey) President Prof. Dr. Adil Mardinoğlu and General Secretary Prof. Dr. Hasan Türkez visited Izmir Biomedicine and Genome Center (IBG).

tuseb visit

Dr. Nejat F. Eczacibasi Medical Students Project Award

Aug. 15, 2019

One of IBG’s research laboratory personnel Sena ALPTEKIN has received the “Dr. Nejat F. Eczacibasi Medical Students Project Award”, which is given to coordinators of successful scientific research projects conducted by medical students.

Three IBG projects will receive funding according to the Evaluation Results of the 1003 Priority Area R&D Funding Programme

July 10, 2019

14 out of 358 applications made to the TUBITAK 1003 SBAG support group have been accepted and we are pleased to announce that 3 of these are projects of IBG.

IBG hosted a one of a kind EMBO course on “Research to service: Planning and running a bioinformatics core facility”

July 9, 2019

The EMBO practical course organized during 8-12 April 2019 at IBG.

Bioinformatics, EMBO practical course

IBG VISIT OF DEPUTY MINISTERS OF INDUSTRY AND TECHNOLOGY

June 26, 2019

Deputy Ministers of Industry and Technology, Mr Mehmet Fatih Kacır and Mr. Çetin Ali Dönmez visited İzmir Biomedicine and Genome Center (IBG)

The second joint meeting of the newly established “DEU-IBG Brain Research Platform” was held on April 24, 2019 at IBG.

May 8, 2019

The second joint meeting of the newly established “DEU-IBG Brain Research Platform” was held on April 24, 2019 at IBG.

ibg brain search platform

BAGEP 2019 SCIENCE ACADEMY'S YOUNG SCIENTIST AWARDS

April 29, 2019

The BAGEP 2019 Awards, which were initiated by the Science Academy in order to encourage youth to engage in good science and reward best practices, found their owners.

BAGEP Awards

Well-Confined Mucosal Laser Ablation with a Negative Pressure Based Endoscopy Capsule - CLEAN

April 4, 2019

We are pleased to inform you that the European Commission has awarded a research grant to support the CLEAN project to be conducted by Serhat Tozburun, PhD.

EMBO bioinformatics core facility management course

March 19, 2019

EMBO Practical Course - Research to service: planning and running a bioinformatics core facility

EMBO Practical Course

A "Brain Research Platform" is being established at IBG

March 19, 2019

The first joint meeting to establish a ‘Brain Research Platform’ at IBG was held on 13 March 2019 at IBG Aziz Sancar Auditorium with the participation of faculty members of Dokuz Eylul University and IBG researchers.

Leader Women in Science and Technology Event

March 1, 2019

Leader Women in Science and Technology Event

IBG will be at PharmaNEXT - Pharmaceutical Industry, Technology and Ingredients Exhibition on 17 -19 April 2019

Feb. 22, 2019

IBG will be at PharmaNEXT - Pharmaceutical Industry, Technology and Ingredients Exhibition on 17 -19 April 2019

ibg pharmanext

Meeting on developing cooperation in translational research with the participation of faculty members of DEU, Departments of Psychiatry and Neurology

Feb. 20, 2019

A meeting was held on 5 February 2019 with the participation of faculty members of Dokuz Eylul University, Departments of Psychiatry and Neurology with the aim of developing cooperation in translational research

cooperation translational research.

ADVISORY BOARD MEMBER PROF. DR. BANU ONARAL’S IBG VISIT

Jan. 23, 2019

Prof. Dr. Banu Onaral, who is a H.H. Sun Professor at Drexel University (Biomedical Engineering) as well as a member of IBG’s Advisory Board, visited IBG on Wednesday, 2 January 2019.

TÜBİTAK President Prof. Dr. Hasan MANDAL’s IBG visit

Jan. 9, 2019

TÜBİTAK President Prof. Dr. Hasan MANDAL visited our university (Dokuz Eylül University, DEÜ) and our center (Izmir Biomedicine and Genome Center, IBG).

Three members of IBG received 2018 TÜBA-GEBİP Awards

Jan. 3, 2019

Three members of IBG received 2018 TÜBA Awards

2018 tuba awards

Dr. Serap Erkek's study has been published in Cancer Cell journal

Jan. 3, 2019

Dr. Serap Erkek's study has been published in Cancer Cell journal

serap erkek cancer cell

Assoc. Prof. Güneş Özhan Baykan receives Parlar Foundation Incentive Award

Dec. 26, 2018

Assoc. Prof. Güneş Özhan Baykan receives Parlar Foundation Incentive Award

gunes ozhan baykan parlar foundation award intensive

Dr. Serap Erkek received EMBO installation grant

Dec. 25, 2018

Dr. Serap Erkek received EMBO installation grant.

serap erkek embo installation grant

TURKEY'S FIRST VENTURE CAPITAL FUND IN THE PHARMA SECTOR IS ESTABLISHED

Nov. 20, 2018

IBG’s Project Application Submitted to the Tech-InvesTR-2018 Venture Capital Funding Programme Was Accepted

AZIZ SANCAR BOOK PUBLISHED BY TUBITAK POPULAR SCIENCE PUBLICATIONS

Nov. 16, 2018

AZIZ SANCAR BOOK PUBLISHED BY TUBITAK POPULAR SCIENCE PUBLICATIONS

PROF. DR. MEHMET ÖZTÜRK'S SPEECH ON BIOTECHNOLOGICAL DRUGS FOR THE EKONOMIST MAGAZINE

Nov. 9, 2018

PROF. DR. MEHMET ÖZTÜRK'S SPEECH ON BIOTECHNOLOGICAL DRUGS FOR THE EKONOMIST MAGAZINE

ASSOC. PROF. SINAN GUVEN RECEIVED TUSEB AZIZ SANCAR ENCOURAGEMENT AWARD IN THE FIFTH TURKISH MEDICAL WORLD CONGRESS

Oct. 31, 2018

ASSOC. PROF. SINAN GUVEN RECEIVED TUSEB AZIZ SANCAR ENCOURAGEMENT AWARD IN THE FIFTH TURKISH MEDICAL WORLD CONGRESS

DR. GONUL VELICELEBI'S `DISCOVERY AND DEVELOPMENT OF SMALL MOLECULE DRUGS FOR CNS DISEASES` ENTITLED PRESENTATION

Oct. 9, 2018

DR. GONUL VELICELEBI'S `DISCOVERY AND DEVELOPMENT OF SMALL MOLECULE DRUGS FOR CNS DISEASES` ENTITLED PRESENTATION

NOBEL PRIZES 2018 IN PHYSIOLOGY OR MEDICINE, CHEMISTRY, AND PHYSICS

Oct. 5, 2018

NOBEL PRIZES 2018 IN PHYSIOLOGY OR MEDICINE, CHEMISTRY, AND PHYSICS

PROF. DR. MEHMET OZTURK WAS PRESENTED AN HONOR AWARD BY THE TURKISH PHARMACISTS' ASSOCIATION ACADEMY OF PHARMACY

Sept. 26, 2018

PROF. DR. MEHMET OZTURK WAS PRESENTED AN HONOR AWARD BY THE TURKISH PHARMACISTS' ASSOCIATION ACADEMY OF PHARMACY

6TH INTERNATIONAL CONGRESS OF THE MOLECULAR BIOLOGY ASSOCIATION OF TURKEY WAS HELD AT IBG

Sept. 14, 2018

6TH INTERNATIONAL CONGRESS OF THE MOLECULAR BIOLOGY ASSOCIATION OF TURKEY WAS HELD AT IBG

ASSOC.PROF.DR. CAN KUCUK IS AWARDED WITH AMERICAN SOCIETY OF HEMATOLOGY AWARD

Sept. 5, 2018

Assoc.Prof.Dr. Can Kucuk's ASH Award

OUTSTANDING SUCCESS ON ACCEPTANCE OF TUBITAK PROJECT SUBMISSIONS IN IBG

Sept. 4, 2018

TUBITAK 1001, TUBITAK 3501, IBG

TUBITAK 1001 TUBITAK 3501 projects

POSTDOC ANNOUNCEMENT FOR COMPUTATIONAL BIOLOGIST

Aug. 2, 2018

We are looking for an experienced bioinformatician / computational biologist to design and analyze genomic experiments aimed to understand the role of various innate and innate-like immune cells in cancer and autoimmunity.

post-doc, computational biologist, bioinformatics

MOLECULAR BIOLOGY CONGRESS

July 28, 2018

The 6th International Congress of the Molecular Biology Association of Turkey (MolBiyoKon) organized by Izmir Biomedicine and Genome Center (IBG) will be held in Izmir between 5-8 September 2018 at Dokuz Eylul University.

GREAT INTEREST IN IBG OPEN DAY

May 30, 2018

IBG Open Day took place on 19 May 2018 at İzmir Biomedicine and Genome Center with the aim of introducing IBG research areas to university students.

INTERNATIONAL WORKSHOP AND SYMPOSIUM ON BIOBANKS

May 25, 2018

An international workshop on “Biobanking for Rare Diseases” and a symposium on "Bridging Biobanks in MENA Countries to Promote Research and Healthcare” took place in Izmir, Turkey between 2-4 May 2018.

BAGEP 2018 YOUNG SCIENTIST AWARD: DUYGU SAĞ

May 4, 2018

Assoc. Prof. Duygu SAĞ was awarded the 2018 "Young Scientist" award within the scope of the BAGEP programme conducted by the Science Academy to support highly talented young scientists.

NATIONAL COLLABORATION AGAINST LIVER CANCER: BRIAN CARR

April 7, 2018

The HCC research team has members from different universities in Turkey.

BREAKING THE ANTIBIOTIC RESISTANCE: EZGİ KARACA

March 30, 2018

Transposase-DNA Complex Structures Reveal Mechanisms for Conjugative Transposition of Antibiotic Resistance

IMMUNE SIGNATURE OF ASTHMA SUSCEPTIBILITY: GERHARD WINGENDER

March 29, 2018

IBG researcher Assist. Prof. Gerhard Wingender and his international colleagues describe two new factors that predict asthma susceptibility.

A RECORD IN DOPPLER ANGIOGRAPHY: SERHAT TOZBURUN

March 27, 2018

The Most Advanced Ultra-fast, Four-dimensional Angiography

UNESCO-LOREAL INTERNATIONAL RISING TALENT: DUYGU SAĞ

March 26, 2018

Assoc.Prof. Duygu Sağ, an immunology group leader at Izmir Biomedicine and Genome Center (IBG), is one of the 15 promising female scientists recognized as ‘International Rising Talents’ this year by the L’Oréal-UNESCO for Women in Science Programme

INTERNATIONAL PROJECT SUPPORTED BY THE BRITISH COUNCIL AND TUBITAK: GÜNEŞ ÖZHAN

March 25, 2018

Assoc. Prof. Güneş Özhan has recently been awarded a "Newton-Kâtip Çelebi Fund Institutional Links Grant" by the British Council and TUBITAK Bilateral Cooperation Programme.

WOMEN'S DAY

March 8, 2018

International Women’s Day was celebrated at IBG.

IS LOVE GENETIC?

Dec. 26, 2017

Prof. Mehmet Öztürk attracts attention with his speech.

Genetics, Scientific Talks

Grant Support from the Horizon 2020

Dec. 20, 2017

IBG is happy to announce that Assoc. Prof. Duygu Sag and Assist. Prof. Gerhard Wingender have been awarded with grant support from the Horizon 2020 Marie Curie Actions RISE program of the European Commission.

IBG featured in the ‘Science and Technology for All’ (HBT) weekly science magazine

Dec. 12, 2017

Editor Orhan Bursalı’s report on IBG and his interview with our director Prof. Dr. Mehmet Ozturk (in Turkish).

Bioinformatics Tool has been released

Nov. 21, 2017

A new bioinformatics tool of IBG has been released

bioinformatic tool

Hürriyet Ege: “Izmir Biomedicine and Genome Center is Equivalent to Harvard”

Nov. 19, 2017

From Ayçe DİKMEN:

COLLABORATIVE STUDY IDENTIFIES MOLECULAR CAUSE OF A NEURODEVELOPMENTAL CONDITION

None

An international collaboration, involving Dr. Yavuz OKTAY and Prof. Dr. Semra HIZ, found gene variants that lead to a neurodevelopmental human disease. The data is published in American Journal of Human Genetics

TUBITAK AND TUBA 2021 SCIENCE AWARDS CEREMONY

None

At the award ceremony held under the auspices of T.C. President Recep Tayyip ERDOĞAN, IBG research group leader Dr. Arif Engin ÇETİN received the incentive award from the President.